Log In
BCIQ
Print this Print this
 

dermaPACE

  Manage Alerts
Collapse Summary General Information
Company Sanuwave Health Inc.
DescriptionExtracorporeal shock wave therapy delivered using Pulsed Acoustic Cellular Expression (PACE) technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentMarketed
Standard IndicationDermal ulcers
Indication DetailsTreat chronic diabetic foot ulcers; Treat diabetic foot ulcer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/01/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today